Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends Arnaldo FigueiredoLuís CostaCarlos Martins-da-Silva Review Article Open access 13 July 2022 Pages: 631 - 642
Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy Daniel Tobias MichaeliJulia Caroline MichaeliThomas Michaeli Original Research Article Open access 11 July 2022 Pages: 643 - 656
Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet Mohamed BadawiXin ChenAhmed Hamed Salem Original Research Article Open access 13 July 2022 Pages: 657 - 668
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study Matteo RuggeriAlessandro SignoriniTariq Al Musawi Original Research Article 15 July 2022 Pages: 669 - 678
Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer Chao LiJanet K. HortonAndrew Beelen Original Research Article Open access 16 July 2022 Pages: 679 - 692
Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19 Noa Berar YanayIdo BognerElias Tannous Research Letter 11 July 2022 Pages: 693 - 695
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports Alberto QuinziiCamilla ZecchettoDavide Melisi Research Letter 19 July 2022 Pages: 697 - 701
Correction to: Foreword Beatriz MínguezJosé Luis Lledó-Navarro Correction Open access 05 July 2022 Pages: 703 - 703
